GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avinger Inc (NAS:AVGR) » Definitions » Beneish M-Score

Avinger (Avinger) Beneish M-Score : -3.17 (As of May. 24, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Avinger Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.17 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Avinger's Beneish M-Score or its related term are showing as below:

AVGR' s Beneish M-Score Range Over the Past 10 Years
Min: -6.96   Med: -3.17   Max: -0.66
Current: -3.17

During the past 12 years, the highest Beneish M-Score of Avinger was -0.66. The lowest was -6.96. And the median was -3.17.


Avinger Beneish M-Score Historical Data

The historical data trend for Avinger's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avinger Beneish M-Score Chart

Avinger Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -3.18 -3.27 -2.77 -4.42

Avinger Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.37 -3.88 -3.99 -4.42 -3.17

Competitive Comparison of Avinger's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Avinger's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avinger's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avinger's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Avinger's Beneish M-Score falls into.



Avinger Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Avinger for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.4767+0.528 * 1.4905+0.404 * 0.9229+0.892 * 0.9214+0.115 * 0.863
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1904+4.679 * -0.252372-0.327 * 1.182
=-3.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was $1.38 Mil.
Revenue was 1.859 + 1.906 + 1.817 + 2.041 = $7.62 Mil.
Gross Profit was 0.343 + 0.374 + 0.388 + 0.605 = $1.71 Mil.
Total Current Assets was $14.12 Mil.
Total Assets was $16.86 Mil.
Property, Plant and Equipment(Net PPE) was $2.51 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.30 Mil.
Selling, General, & Admin. Expense(SGA) was $14.93 Mil.
Total Current Liabilities was $20.06 Mil.
Long-Term Debt & Capital Lease Obligation was $0.84 Mil.
Net Income was -5.517 + -5.024 + -4.476 + -4.176 = $-19.19 Mil.
Non Operating Income was -0.012 + 0.018 + 0.012 + -0.002 = $0.02 Mil.
Cash Flow from Operations was -4.734 + -3.389 + -3.53 + -3.301 = $-14.95 Mil.
Total Receivables was $1.01 Mil.
Revenue was 1.888 + 2.001 + 2.252 + 2.132 = $8.27 Mil.
Gross Profit was 0.636 + 0.683 + 0.79 + 0.657 = $2.77 Mil.
Total Current Assets was $17.68 Mil.
Total Assets was $20.47 Mil.
Property, Plant and Equipment(Net PPE) was $2.50 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.25 Mil.
Selling, General, & Admin. Expense(SGA) was $13.61 Mil.
Total Current Liabilities was $20.66 Mil.
Long-Term Debt & Capital Lease Obligation was $0.81 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1.377 / 7.623) / (1.012 / 8.273)
=0.180638 / 0.122326
=1.4767

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2.766 / 8.273) / (1.71 / 7.623)
=0.334341 / 0.224321
=1.4905

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (14.121 + 2.514) / 16.86) / (1 - (17.677 + 2.497) / 20.47)
=0.013345 / 0.01446
=0.9229

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=7.623 / 8.273
=0.9214

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.253 / (0.253 + 2.497)) / (0.3 / (0.3 + 2.514))
=0.092 / 0.10661
=0.863

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(14.93 / 7.623) / (13.611 / 8.273)
=1.958547 / 1.645231
=1.1904

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.835 + 20.064) / 16.86) / ((0.808 + 20.658) / 20.47)
=1.239561 / 1.048657
=1.182

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-19.193 - 0.016 - -14.954) / 16.86
=-0.252372

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Avinger has a M-score of -3.17 suggests that the company is unlikely to be a manipulator.


Avinger Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Avinger's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Avinger (Avinger) Business Description

Traded in Other Exchanges
N/A
Address
400 Chesapeake Drive, Redwood City, CA, USA, 94063
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
Executives
Crg Partners Iii (cayman) Unlev Aiv I L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii (cayman) Lev Aiv I L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii - Parallel Fund B (cayman) L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Cr Group L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii - Parallel Fund (a) L.p. 10 percent owner C/O CAPITAL ROYALTY L.P., 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Nabeel Paul Subainati officer: Vice President, Finance 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
James Cullen director 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Mark Weinswig officer: Chief Financial Officer EMCORE CORP, 10420 RESEARCH ROAD, SE, ALBUQUERQUE NM 87123
Himanshu Patel officer: Chief Technology Officer C/O AVINGER, INC., 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
Jeffrey M Soinski director, officer: President and CEO 585 WEST 500 SOUTH, BOUNTIFUL UT 84010
Tamara Elias director 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
Simpson John B Ph D Md director, 10 percent owner C/O FOXHOLLOW TECHNOLOGIES, INC., 740 BAY ROAD, REDWOOD CITY CA 94063
Matthew Ferguson officer: CBO, CFO & Treasurer C/O FOXHOLLOW TECHNOLOGIES, INC., 740 BAY ROAD, REDWOOD CITY CA 94063
John D. Simpson officer: Sr. VP, Sales & Marketing C/O AVINGER, INC., 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063